Palliative chemotherapy in non-hodgkin’s lymphoma

Oncology (Switzerland)

Volumn 54, Issue 2, 1997, Pages 108-111

  Salminen, E ^a   Nikkanen, V ^a   Lindholm, L ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Non Hodgkin s lymphoma; Oxazaphosphorine; Palliative chemotherapy; Trofosfamide

Indexed keywords

CHLORAMBUCIL; TROFOSFAMIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSS RESISTANCE; FATIGUE; FEMALE; HUMAN; INFECTION; LEUKOPENIA; MALE; NAUSEA; NEUROPATHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STATISTICS; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 0031046843     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227672     Document Type: Article

References (12)

1. Salminen H: The outcome of treatment of 70 years old non-Hodgkin’s lymphoma patients, Int J Radiat Oncol Biol Phys 1995,32:349-353.
2. Zagoncl V, Carbone A, Kerpcl-Fronius S: Management of non-Hodgkin’s lymphoma in elderly patients; in Montardini S (ed): Management of Non-Hodgkin’s Lymphomas, Berlin, Springer, 1990, pp 35-44.
3. Brock N: Oxazaphosphorine cytostatics: Past-present-future, Cancer Res 1989:49:1-7.
4. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfield A, Vaan Unnik J: Classification of non-Hodgkin’s lymphoma, Lancet 1974;2:406-408.
5. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment, Cancer 1981;47:207-214.
6. Connors JM: Adult non-Hodgkin’s lymphomas; in Cvitkovic E, Droz JP, Armand JP, Khoury S (eds): Handbook of Chemotherapy in Clinical Oncology, Jersey, Scientific Communication International, 1993, pp 702-707.
7. Finnish Cancer Society: Cancer incidence in Finland, Helsinki, Finnish Cancer Society, 1995, vol 56.
8. Boos J, Kupker F, Blaschke G, Jiirgens H: Tro-fosfamide metabolism in different species -ifosfamide is the predominant metabolite, Cancer Chemother Pharmacol 1993;33:71-76.
9. Norum J: Complete remission after repeated trofosphamide treatment in relapsing high-grade malignant non-Hodgkin’s lymphoma - a case report, Acta Oncol 1994;33:831.
10. Enblad G, Glimelius B, Hagberg H, Linde-malm M: Methyl-gag, ifosfamide, methotrexate and ctoposide (MIME) as salvage therapy for Hodgkin’s disease and non-Hodgkin’s lymphoma, Acta Oncol 1990;29:297-301.
11. Cabanillas F, Hagemeister F, McLaughlin P, Velasquez W, Riggs S, Fuller L, Smith T: Results of MIME salvage regimen for recurrent or refractory lymphoma, J Clin Oncol 1987,5: 407-412.
12. Wist E, Risberg T: Trofosfamidc in non-Hodg-kin’s lymphoma, Acta Oncol 1991;7:819-821.